22nd Century Group, Inc. XXII
Medicinal Chemicals and Botanical Products · data as of November 13, 2026
22nd Century Group, Inc. (XXII) is a healthcare company listed in the US with a market value of about $424216. In the twelve months to June 30, 2026 it had revenue of $15M and net income of -$4M, a net margin of -27.0%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -9% a year, a 5-year average ROIC of -139%.
About 22nd Century Group
22nd Century Group is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $528991 in 2014 to $18M in 2025, growth of about 37.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 7816413% over three years (dilution for shareholders). It spends 4% of revenue on research and development.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $18M | $24M | $32M | $41M | $31M | $28M | $26M | $26M | $17M | $12M |
| Net income | -$4M | -$5M | -$15M | -$141M | -$60M | -$33M | -$20M | -$27M | -$8M | -$13M | -$12M |
| Free cash flow | -$9M | -$8M | -$14M | -$60M | -$55M | -$24M | -$16M | -$15M | — | — | — |
| EPS (diluted) | $-169.28 | $-52.87 | $-45711.05 | $-39743007.82 | $-25386097.16 | $-17196766.03 | $-11464510.69 | $-17196766.03 | $-4913361.72 | $-10645617.07 | $-12283404.31 |
| Net margin | -27.0% | -28.7% | -62.2% | -437.1% | -147.7% | -105.4% | -70.1% | -102.8% | -30.1% | -78.5% | -94.3% |
| ROIC | — | -67.0% | -89.0% | -478.1% | -25.9% | -32.8% | -33.8% | -37.1% | -32.8% | -17.6% | -46.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does 22nd Century Group pay a dividend?
Not currently.
Is 22nd Century Group a good stock to buy?
We do not give buy or sell advice. 22nd Century Group scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.